L572-0186 Screening compound: 2-[3-(4-chlorobenzenesulfonamido)phenoxy]-N-cyclobutylpyridine-3-carboxamide

L572-0186 Screening compound: 2-[3-(4-chlorobenzenesulfonamido)phenoxy]-N-cyclobutylpyridine-3-carboxamide
L572-0186 Screening compound: 2-[3-(4-chlorobenzenesulfonamido)phenoxy]-N-cyclobutylpyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L572-0186
2-[3-(4-chlorobenzenesulfonamido)phenoxy]-N-cyclobutylpyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L572-0186

Molecular Formula

C22H20ClN3O4S (C22 H20 ClN3 O4 S)

Compound Name

2-[3-(4-chlorobenzenesulfonamido)phenoxy]-N-cyclobutylpyridine-3-carboxamide

IUPAC name

2-[3-(4-chlorobenzenesulfonamido)phenoxy]-N-cyclobutylpyridine-3-carboxamide

SMILES

O=C(c1cccnc1Oc1cccc(NS(c(cc2)ccc2Cl)(=O)=O)c1)NC1CCC1

InChI

InChI=1S/C22H20ClN3O4S/c23-15-9-11-19(12-10-15)31(28,29)26-17-6-2-7-18(14-17)30-22-20(8-3-13-24-22)21(27)25-16-4-1-5-16/h2-3,6-14,16,26H,1,4-5H2,(H,25,27)

InChI Key

UUOYVNJTLVZPKL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27463360

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.94

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.525

Distribution Coefficient, logD

4.479

Water Solubility, LogSw

-4.86

Polar Surface Area

81.911

Acid Dissociation Constant (pKa)

8.35

Base Dissociation Constant (pKb)

0.53

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

L572-0186 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

C-Met Library (15277 compounds)

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L572-0186 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L572-0186?
Check Price and Availability of L572-0186, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L572-0186 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L572-0186
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L572-0186
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L572-0186 available by request